4.8 Article

Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites

Related references

Note: Only part of the references are listed.
Article Immunology

T-cell immunoglobulin- and mucin-domain-containing molecule-4 maintains adipose tissue homeostasis by orchestrating M2 macrophage polarization via nuclear factor kappa B pathway

Lu Ding et al.

Summary: Tim-4 is a critical switch that regulates macrophage polarization and maintains adipose tissue homeostasis. Its deficiency may lead to obesity. Tim-4 promotes M2-like macrophage polarization by suppressing the NF-κB signaling pathway.

IMMUNOLOGY (2023)

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Biotechnology & Applied Microbiology

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy

Meng Wang et al.

Summary: The dual-targeting nanomedicine, PG@KMCM, was developed to target tumor-associated macrophages and reprogram the tumor microenvironment, enhancing the therapeutic potential against pancreatic cancer. Combination with PD-L1 immune checkpoint inhibitor further improved the anti-tumoral effect by reprograming the immune-suppressive tumor microenvironment.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Review Immunology

Metabolic Regulation of Macrophage Activation

Ourania Kolliniati et al.

Summary: Macrophages, as central mediators of innate immune responses, adapt to different environments and nutritional resources by utilizing energy at both normoxic and hypoxic conditions and modulating signaling pathways to shape different activation phenotypes. Systemic changes in diseases can also affect macrophage metabolism, resulting in altered activation phenotypes in adipose tissue or in the periphery.

JOURNAL OF INNATE IMMUNITY (2022)

Article Chemistry, Multidisciplinary

Polarization of Tumor-Associated Macrophages Promoted by Vitamin C-Loaded Liposomes for Cancer Immunotherapy

Zhaoyu Ma et al.

Summary: By delivering vitamin C to the tumor site using responsive lipid nanoparticles, oxidative toxicity and polarization of M1 macrophages can be induced, promoting the infiltration of cytotoxic T lymphocytes in the tumor microenvironment and enhancing immune checkpoint blocking therapy. This approach shows better immune response than using clinical Anti-PD-L1 alone, providing a new therapeutic application for patients with clinically insensitive immunity.

ACS NANO (2022)

Review Medicine, General & Internal

Hepatocellular carcinoma

Arndt Vogel et al.

Summary: Hepatocellular carcinoma is a common cancer worldwide, with non-alcoholic fatty liver disease becoming a dominant cause. Treatment options are varied, including surgery, radiation, and medication. With the approval of new drugs and the development of immunotherapy, the outlook for hepatocellular carcinoma patients has improved, but the optimal sequencing of drugs and predictive biomarkers still need further research.

LANCET (2022)

Article Biochemistry & Molecular Biology

TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization

Yicheng Han et al.

Summary: TMP195, a selective class IIa HDAC inhibitor, has been found to reduce tumor burden in mouse models of colitis-associated colorectal cancer (CAC) and subcutaneous tumor. It promotes polarization of macrophages, leading to increased release of inflammatory cytokines, and enhances the efficacy of PD-1 blockade.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Oncology

Macrophage-Based Approaches for Cancer Immunotherapy

Nicholas R. Anderson et al.

Summary: Adoptive cell therapy with genetically modified T cells has shown promising results in hematologic malignancies, but applying it to solid tumors has been challenging. This has led to the investigation of alternative immune cells as therapeutic options. Macrophages have functional plasticity that can be harnessed for both antitumor and protumor effects, leading to efforts to deplete or repolarize tumor-associated macrophages, as well as exploring the potential of adoptively transferring genetically modified macrophages.

CANCER RESEARCH (2021)

Review Immunology

Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells

Benjamin Ruf et al.

Summary: Immune-based therapies, particularly immune checkpoint inhibitors, have shown significant improvements in the treatment of hepatocellular carcinoma (HCC), but durable responses are limited to a subset of patients. Understanding the immunologic mechanisms shaping the unique tumor microenvironment of liver cancer is crucial for developing effective therapeutic strategies. Current research focuses on targeting immune cells within the liver to enhance the therapeutic potential of immunotherapeutic agents.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Nanoscience & Nanotechnology

Inducing immune tolerance with dendritic cell-targeting nanomedicines

Anna Cifuentes-Rius et al.

Summary: Induced tolerogenic dendritic cells offer a promising immunotherapy for autoimmune diseases, with nanomedicine presenting an alternative approach to overcome cost and customization limitations. By targeting dendritic cells with nanoparticles, this technology has the potential to address critical issues in organ transplantation and prevalent autoimmune disorders.

NATURE NANOTECHNOLOGY (2021)

Article Pharmacology & Pharmacy

Polystyrene microplastics cause granulosa cells apoptosis and fibrosis in ovary through oxidative stress in rats

Ru An et al.

Summary: The study reveals that polystyrene microplastics have negative effects on rat ovaries by activating the Wnt/β-Catenin signaling pathway, leading to ovarian fibrosis and granulosa cell apoptosis. This ultimately results in decreased ovarian reserve capacity.

TOXICOLOGY (2021)

Article Engineering, Biomedical

Targeted PD-L1 PLGA/liposomes-mediated luteolin therapy for effective liver cancer cell treatment

Xinqiao Cao et al.

Summary: Stealth PLGA/Liposome nanoparticles modified with tumor-targeting PD-L1 antibody were prepared for systemic delivery of luteolin for liver cancer treatment. The nanoparticles showed enhanced drug uptake and inhibition of liver cancer cell proliferation, indicating their potential as an effective drug delivery system targeting PD-L1.

JOURNAL OF BIOMATERIALS APPLICATIONS (2021)

Article Oncology

Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity

Andrew Chow et al.

Summary: The study revealed that metastatic cancer in the pleural and peritoneal cavities leads to poor clinical outcomes after immune checkpoint blockade therapy, mainly due to the high expression of Tim-4 by cavity-resident macrophages, which suppresses tumor-reactive CD8(+) T cells. Blocking Tim-4 can enhance the efficacy of immunotherapy in these microenvironments.

CANCER CELL (2021)

Article Chemistry, Multidisciplinary

Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies

Yang Liu et al.

Summary: Manipulation of tumor-associated macrophages (TAMs) has been identified as a key factor in improving immunotherapies, with inhibition of the NF-kappa B pathway potentially impacting both PD-1/PD-L1 and NF-kappa B pathways simultaneously. Co-loading PD-1 antibody and NF-kappa B pathway inhibitor in nanocarriers has shown promising results in enhancing the efficacy of immunotherapies.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Oncology

Tunnelled Peritoneal Catheter for Malignant Ascites-An Open-Label, Prospective, Observational Trial

Golo Petzold et al.

Summary: Recurrent abdominal fluid collection, or ascites, is a common issue in patients with advanced malignancy, causing discomfort and other symptoms. Tunnelled peritoneal PleurX catheters have been shown to effectively reduce ascites-related symptoms and hospitalization rates, and are a safe and routine option for patients with recurrent malignant ascites.

CANCERS (2021)

Article Immunology

Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer

Anders Etzerodt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Engineering, Biomedical

Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle

Chelsea A. Kraynak et al.

ACTA BIOMATERIALIA (2020)

Review Immunology

Tim-4 in Health and Disease: Friend or Foe?

Wen Liu et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy

Yan Zhao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Biochemistry & Molecular Biology

Targeting STAT3 in Cancer Immunotherapy

Sailan Zou et al.

MOLECULAR CANCER (2020)

Article Biophysics

Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer

Paweena Dana et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2020)

Review Oncology

Turning Cold into Hot: Firing up the Tumor Microenvironment

Qianqian Duan et al.

TRENDS IN CANCER (2020)

Review Immunology

M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds

Youhan Wang et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

Article Multidisciplinary Sciences

Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes

Shoji Maeda et al.

SCIENCE (2019)

Article Multidisciplinary Sciences

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

Amira A. Barkal et al.

NATURE (2019)

Review Immunology

The Immunology of Macrophage Activation Syndrome

Courtney B. Crayne et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Gastroenterology & Hepatology

Management of ascites and hepatorenal syndrome

Salvatore Piano et al.

HEPATOLOGY INTERNATIONAL (2018)

Review Biochemistry & Molecular Biology

Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents

Matteo Santoni et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Review Cell Biology

The biology of serous cavity macrophages

Calum C. Bain et al.

CELLULAR IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies

Ahmed Sabt et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)

Editorial Material Medicine, General & Internal

Immune oncology in hepatocellular carcinoma-hype and hope

Marcus-Alexander Woerns et al.

LANCET (2017)

Article Multidisciplinary Sciences

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero et al.

NATURE (2017)

Article Multidisciplinary Sciences

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

Sydney R. Gordon et al.

NATURE (2017)

Review Oncology

Sorafenib: A Review in Hepatocellular Carcinoma

Gillian M. Keating

TARGETED ONCOLOGY (2017)

Review Medicine, Research & Experimental

A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer

Ayman Shafei et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Biotechnology & Applied Microbiology

Tim-3 and Tim-4 as the potential targets for antitumor therapy

Lin Cheng et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Article Medicine, Research & Experimental

Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory

Thomas B. Thornley et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Chemistry, Multidisciplinary

PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide Delivery

Peng Zou et al.

PHARMACEUTICAL RESEARCH (2014)

Review Immunology

Innate and adaptive immune cells in the tumor microenvironment

Thomas F. Gajewski et al.

NATURE IMMUNOLOGY (2013)

Article Health Care Sciences & Services

Palliative Chemotherapy for Malignant Ascites Secondary to Ovarian Cancer

Yuliya Malayev et al.

AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2012)